Uncategorised - European Medical Journal

Advances in proteinuria-targeting therapy in IgAN

Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with IgA…

Lupus in Pregnancy Linked to Placental Damage

Systemic lupus erythematosus impacts placental health, particularly in pregnancies resulting in small for gestational age infants.

CDC Warns of Rising Pneumonia and RSV in Children

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

Carlos Caldas

Onc Now: Episode 3: Redefining Breast Cancer

This week, Jonathan Sackier is joined by Carlos Caldas, a world-leading expert in breast cancer research and clinician scientist at the University of Cambridge.

Genetic Risk of Hidradenitis Suppurativa Linked to Cardiometabolic Disease

A cohort study has examined whether an increased genetic risk of hidradenitis suppurativa is linked to a higher likelihood of developing cardiometabolic diseases.

First COVID Vaccine Increases Cardiovascular Risks; Full Course Provides Protection

COVID-19 vaccination is associated with a transient increase in cardiovascular risks, but complete vaccination significantly reduces the risk of more severe cardiovascular events.

Interview: Chesahna Kindred

Now, as a practicing physician, I have no insecurities about being a woman in business, because in my training, I would be in a room with hundreds of women at the Women’s Dermatological Society.

The Androgen Deprivation Therapy Landscape in 2024 – Co-navigating the Available Options with Prostate Cancer Patients

This industry symposium took place on 5th April 2024 during the 39th Annual European Association of Urology (EAU) Congress in Paris, France…

ARS' Richard Lowenthal on his mission to transform allergy care

Richard Lowenthal, CEO, ARS Pharmaceuticals, reveals the company’s mission to address unmet needs in allergy care with its new nasal spray.

Ketamine Treatment for Bipolar Shows Full Remission

Ketamine treatment for bipolar depression may offer new hope, as new research has revealed its potential as a treatment option in real-world settings to significantly reduce symptoms in patients resistant to traditional therapies.